Targeting First Paper in Cardiology Journal Club 🫀

This presentation introduces the concept of a cardiology journal club, emphasizing the importance of staying engaged with cardiovascular research. It explores the TARGET-FIRST trial, assessing aspirin cessation in ACS management post-PCI, focusing on reduced bleeding and efficacy outcomes. Key implications for clinical practice include personalized therapy approaches, balancing ischemic and bleeding risks, and aligning with evolving guidelines. The session concludes with a summary of...